StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
KVT.WA$13.00+2.36%
Fair $13.00+0.0%

KVT.WA

Krynica Vitamin S.A.

Consumer Defensive / Beverages - Non-AlcoholicWarsaw

$13.00

+0.30 (+2.36%)

Fairly Valued+0.0%Fair Value $13.00Fund rank 32/100 · Data gapFallback financials|
SA 59/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 25%

FCF escenarios

weak_data · normalized FCF $20.2M · quality 63.3/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 42/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

59/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · KVT.WALocal privado en este navegador · Krynica Vitamin S.A.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$159M

P/E

13.4x

↓

EV/EBITDA

6.0x

↓

ROE

11.6%

↑

Gross Margin

17.0%

↓

Debt/Equity

0.29

↓
52-Week Range$13
$9$13

TradingView lightweight chart

KVT.WA price, volumen y niveles de valoración

Último $13.00Periodo +74.3%
Fair value: $13.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-1.9%

FCF CAGR

—

FCF margin

6.9%

FCF / Net income

2.07x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $356.3M · net income $12.0M · FCF $24.7M

2022-FY → 2025-FY

Gross margin

17.0%-0.6% pts

Operating margin

5.9%+0.3% pts

Net margin

3.4%-0.1% pts

FCF margin

6.9%+7.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$356.3M$356.3M$387.9M$359.2M$377.2M
Net Income$12.0M$12.0M$12.2M$-6.7M$13.1M
EBITDA$31.4M$31.4M$31.6M$12.3M$31.3M
EPS0.980.981.00-0.551.07
Gross Margin17.0%17.0%16.6%14.4%17.6%
Operating Margin5.9%5.9%4.6%2.4%5.5%
Net Margin3.4%3.4%3.2%-1.9%3.5%
Balance Sheet
Debt/Equity0.290.290.520.800.78
Current Ratio0.950.95———
Cash Flow
Free Cash Flow$24.7M$24.7M$20.2M$13.7M$-1.8M
Returns
ROE11.6%11.6%13.0%-8.2%14.4%
Valuation
P/E13.4013.408.62—11.99
EV/EBITDA6.016.014.8919.337.25
P/B1.551.551.122.131.72
Growth & Yield
Revenue Growth-8.2%-8.2%8.0%-4.8%—
EPS Growth-2.2%-2.2%283.1%-151.0%—
Dividend Yield4.8%4.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

5.7%

razonable

EPS terminal req.

$1.15

Spread vs growth

-7.9%

5Y implied EPS CAGR

7.4%

razonable

EPS terminal req.

$1.40

Spread vs growth

-9.6%

10Y implied EPS CAGR

8.7%

razonable

EPS terminal req.

$2.25

Spread vs growth

-10.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +39.3%

Total return

+39.3%

Start / end P/E

9.7x → 13.3x

EPS bridge

1.00 → 0.98

Residual

-0.8%

EPS growth-2.2%
Multiple rerating+37.6%
Dividend+4.8%
Residual / FX / buybacks / cross-term-0.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.